Alnylam Pharmaceuticals (ALNY) PT Raised to $280 at JPMorgan
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $223.95 +1.24%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
JPMorgan analyst Jessica Fye raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $280.00 (from $248.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Tokyo Tatemono Co Ltd (8804:JP) PT Raised to JPY4,480 at Nomura/Instinet
- Square Enix Holdings (9684:JP) (SQNNY) PT Raised to JPY2,950 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
